Article Text

Download PDFPDF
CASE REPORT
Use of cabergoline for the management of persistent Cushing’s disease in pregnancy
  1. Kathleen Su-Yen Sek,
  2. Doddabele Srinivasa Deepak,
  3. Kok Onn Lee
  1. Department of Medicine, National University Hospital, Singapore, Singapore
  1. Correspondence to Dr Kathleen Su-Yen Sek, kathleen_sy_sek{at}nuhs.edu.sg

Summary

Cushing’s disease (CD) is rare during pregnancy and is associated with significant maternal and fetal complications. It is important to control hypercortisolism during pregnancy, either surgically or medically, for a successful maternal and fetal outcome. We report a patient with recurrent CD who was treated with low-dose cabergoline (CAB) for persistent hypercortisolism throughout pregnancy. A 36-year-old woman was diagnosed with CD at the age of 23. She underwent trans-sphenoidal surgery with initial complete remission. However, 4 years after surgery, CD recurred and she underwent Gamma Knife radiosurgery (GKRS). Following GKRS, her cortisol levels remained elevated despite no evidence of visible tumour on pituitary MRI. Medical treatment was commenced with ketoconazole and cyproheptadine. This was changed to CAB as she was keen for pregnancy. She conceived spontaneously and was on CAB throughout pregnancy. She delivered a healthy male neonate, weighing 3195 g at 40 weeks of gestation.

  • endocrine system
  • pregnancy
  • pituitary disorders

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors KO was involved in the care of the patient and conceived this study. KSS wrote the first draft. KSS, DSD and KOL reviewed and revised the draft. All authors approved the submitted version of the manuscript.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.